[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
July 31, 1937

The Treatment of Diabetes Mellitus

JAMA. 1937;109(5):383. doi:10.1001/jama.1937.02780310061024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

This book has been conspicuous on the diabetic horizon for the last twenty years. It was conceived during the preinsulin epoch, was developed during the insulin epoch, and now thrives in a period which the author has named the Hagedorn era. Indeed, its revision so soon after publication of the fifth edition was necessitated by the discovery of protamine insulin by the distinguished Hagedorn and his associates of Copenhagen, whose report was published in The Journal, Jan. 18, 1936. The Hagedorn era has already been shown to be an improvement for the diabetic patient. Protamine insulin, Joslin says, is the most notable advance in the treatment of diabetes since the discovery of insulin in 1921. The action of regular insulin was dramatic in lowering the blood sugar, but its effect was temporary and most cases required two, three or even four injections a day. With protamine insulin the injections may

First Page Preview View Large
First page PDF preview
First page PDF preview
×